open access

Vol 8, No 5 (2019)
ORIGINAL ARTICLES
Published online: 2019-11-28
Get Citation

Functional activities of neutrophils in diabetic rats are changed by yacon extracts

Mariia Nagalievska, Mariya Sabadashka, Halyna Hachkova, Nataliia Sybirna
DOI: 10.5603/DK.2019.0023
·
Clinical Diabetology 2019;8(5):248-253.

open access

Vol 8, No 5 (2019)
ORIGINAL ARTICLES
Published online: 2019-11-28

Abstract

Introduction. Characterization of the polymorphonuclear neutrophils functional activity during the diabetes is of outmost importance for the understanding of the immunological processes involved in disease pathogenesis. The search for effective drugs that would suppress and/or modulate the immune response, preferably without negative effects, is a promising area of modern research. Smallanthus sonchifolius Poepp. et Endl., which has long been used in folk medicine to treat diabetes, was proposed as a potential treatment for immune disorders. The study aimed to search for the effective drug which would be able to regulate neutrophils functional activity in experimentally induced type 1 diabetes mellitus.

Material and methods. The experiments were conducted on male Wistar rats. Diabetes was induced by intraabdominal injection of streptozotocin. For the evaluation of phagocytic activity and the content of cationic proteins and myeloperoxidase in neutrophils cytochemical studies were performed.

Results. Diabetes development was accompanied by reduced phagocytic activity of granulocytes and increased activity of myeloperoxidase. All used extracts intensified phagocytic activity of neutrophil in diabetes, with the yacon root tubers extract demonstrating the strongest effect, which was reflected by rapid degradation of particles engulfed by phagocytes.

Conclusions. It was established that yacon extracts inhibit myeloperoxidase activity in diabetes. Therefore all investigated extracts have a pronounced immunocorrective effect and can become the basis for creating a new generation of antidiabetic drugs.

Abstract

Introduction. Characterization of the polymorphonuclear neutrophils functional activity during the diabetes is of outmost importance for the understanding of the immunological processes involved in disease pathogenesis. The search for effective drugs that would suppress and/or modulate the immune response, preferably without negative effects, is a promising area of modern research. Smallanthus sonchifolius Poepp. et Endl., which has long been used in folk medicine to treat diabetes, was proposed as a potential treatment for immune disorders. The study aimed to search for the effective drug which would be able to regulate neutrophils functional activity in experimentally induced type 1 diabetes mellitus.

Material and methods. The experiments were conducted on male Wistar rats. Diabetes was induced by intraabdominal injection of streptozotocin. For the evaluation of phagocytic activity and the content of cationic proteins and myeloperoxidase in neutrophils cytochemical studies were performed.

Results. Diabetes development was accompanied by reduced phagocytic activity of granulocytes and increased activity of myeloperoxidase. All used extracts intensified phagocytic activity of neutrophil in diabetes, with the yacon root tubers extract demonstrating the strongest effect, which was reflected by rapid degradation of particles engulfed by phagocytes.

Conclusions. It was established that yacon extracts inhibit myeloperoxidase activity in diabetes. Therefore all investigated extracts have a pronounced immunocorrective effect and can become the basis for creating a new generation of antidiabetic drugs.

Get Citation

Keywords

yacon; leukocytes; phagocytosis; myeloperoxidase; diabetes mellitus

About this article
Title

Functional activities of neutrophils in diabetic rats are changed by yacon extracts

Journal

Clinical Diabetology

Issue

Vol 8, No 5 (2019)

Pages

248-253

Published online

2019-11-28

DOI

10.5603/DK.2019.0023

Bibliographic record

Clinical Diabetology 2019;8(5):248-253.

Keywords

yacon
leukocytes
phagocytosis
myeloperoxidase
diabetes mellitus

Authors

Mariia Nagalievska
Mariya Sabadashka
Halyna Hachkova
Nataliia Sybirna

References (20)
  1. Hodgson K, Morris J, Bridson T, et al. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015; 144(2): 171–185.
  2. Khan AA, Alsahli MA, Rahmani AH. Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives. Med Sci (Basel). 2018; 6(2).
  3. Yamaguchi R, Kawata J, Yamamoto T, et al. Mechanism of interferon-gamma production by monocytes stimulated with myeloperoxidase and neutrophil extracellular traps. Blood Cells Mol Dis. 2015; 55(2): 127–133.
  4. Paredes LLR, Smiderle FR, Santana-Filho AP, et al. Yacon fructans (Smallanthus sonchifolius) extraction, characterization and activation of macrophages to phagocyte yeast cells. Int J Biol Macromol. 2018; 108: 1074–1081.
  5. Nagalievska M, Sabadashka M, Hachkova H, et al. Galega officinalis extract regulate the diabetes mellitus related violations of proliferation, functions and apoptosis of leukocytes. BMC Complement Altern Med. 2018; 18(4): 1–13.
  6. Levinsky RJ, Harvey BA, Paleja S. A rapid objective method for measuring the yeast opsonisation activity of serum. J Immunol Methods. 1978; 24(3-4): 251–256.
  7. Shubych MH. [Identification of cationic protein in the cytoplasm of leukocytes using bromophenol blue]. Tsytolohyia. 1974: 1321–1322.
  8. Graham RC, Karnovsky MJ. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructure cytochemistry by a new technique. J Histochem Cytochem. 1966; 14(4): 291–302.
  9. Ratter JM, Tack C, Netea M, et al. Environmental signals influencing myeloid cell metabolism and function in diabetes. Trends Endocrinol Metab. 2018; 29(7): 468–480.
  10. Collison KS, Parhar RS, Saleh SS, et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002; 71(3): 433–444.
  11. Horbulinska O, Khokhla M, Hachkova G, et al. [Influence of yaсon (Smallanthus sonchifolius Poepp. & Endl.) on rats’ blood cells the condition of experimental diabetes mellitus. Visnyk of Lviv University]. Biological Series. 2016; 71: 31–42.
  12. Schorr K, Mefort I, Da Costa FB. A novel dimeric melampolide and further terpenoids from Smallanthus sonchifolius (Asteraceae) and the inhibition of the transcription factor NF-κB. Nat Prod Commun. 2007; 2: 367–374.
  13. Lachman J, Fernandez EC, Orsak M. Yacon [Smallanthus sonchifolia (Poepp. et Endl.) H. Robinson] chemical composition and use — a review. Plant soil environ. 2003; 49(6): 283–90.
  14. Bub A, Watzl B, Blockhaus M, et al. Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J Nutr Biochem. 2003; 14(2): 90–98.
  15. Vogt L, Ramasamy U, Meyer D, et al. Immune modulation by different types of β2→1-fructans is toll-like receptor dependent. PLoS One. 2013; 8(7): e68367.
  16. Gorudko IV, Kostevich VA, Sokolov AV, et al. Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress. Bull Exp Biol Med. 2012; 154(1): 23–26.
  17. Luan H, Kan Z, Xu Y, et al. Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. J Neuroinflammation. 2013; 10: 28.
  18. Zhang Xu, Huang H, Yang T, et al. Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury. Injury. 2010; 41(7): 746–752.
  19. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3(9): 710–720.
  20. Quinn MT, Ammons MC, Deleo FR. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci (Lond). 2006; 111(1): 1–20.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl